COMPOSITIONS PHARMACEUTIQUES COMPRENANT DE LA LÉVODOPA, UN INHIBITEUR DE LA DOPAMINE DÉCARBOXYLASE ET UN INHIBITEUR DE LA COMT, ET LEUR PROCÉDÉ D'ADMINISTRATION
- 专利权人:
- Lobsor Pharmaceuticals Aktiebolag
- 发明人:
- 申请号:
- EP15838800.9
- 公开号:
- EP3188725A4
- 申请日:
- 2015.09.04
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要:
- A pharmaceutical gel composition for intra-intestinal administration comprises (i) a dopamine replacement agent, (ii) a dopamine decarboxylase inhibitor (DDI), and (iii) a COMT inhibitor.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA, A DOPAMINE DECARBOXYLASE INHIBITOR AND A COMT INHIBITOR AND METHOD OF ADMINISTRATION THEREOF
- Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
- Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
- PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA, A DOPAMINE DECARBOXYLASE INHIBITOR AND A COMT INHIBITOR AND METHOD OF ADMINISTRATION THEREOF
- COMBINAISONS POUR LE TRAITEMENT DU NEUROBLASTOME